Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
RA CAPITAL MANAGEMENT, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share (RXRX)
- Filing manager
- RA CAPITAL MANAGEMENT, L.P.
- Reporting owner
- RA Capital Management, L.P.
- Beneficially owned shares
- 7,725,096 shares
- Class ownership
- 2%
- Large-stake signal
-
Ownership
2%Beneficial ownership of this reported class.
Shares
7,725,096 sharesShares beneficially owned as disclosed.
Event date
31 Dec 2024Date tied to the ownership event or amendment.
Accepted by SEC
14 Feb 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Symbol
- RXRX
- Shares outstanding
- 386,254,800 shares
- Form type
- SCHEDULE 13G/A
- Accepted by SEC
- 14 Feb 2025, 18:41:24 UTC
- Event date
- 31 Dec 2024
- SEC filing
- View on sec.gov
Ownership signal
2 signals
Subject security
2 source fields
Source evidence
4 source fields
Key filing fact
RA CAPITAL MANAGEMENT, L.P. disclosed 2% ownership in Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share (RXRX) on 31 Dec 2024.
Key facts
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G/A for Recursion Pharmaceuticals, Inc. Class A Common Stock, par value $0.00001 per share (RXRX).
- Disclosed ownership: 2%.
- Date of event: 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 18:41.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (4)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 2% | 7,725,096 | 0 | 7,725,096 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | |
| Peter Kolchinsky | 2% | 7,725,096 | 0 | 7,725,096 | /s/ Peter Kolchinsky | Peter Kolchinsky | |
| Rajeev Shah | 2% | 7,725,096 | 0 | 7,725,096 | /s/ Rajeev Shah | Rajeev Shah | |
| RA Capital Healthcare Fund, L.P. | 2% | 7,725,096 | 0 | 7,725,096 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager |
CIK / CUSIP context first